Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Hydroxyprogesterone
Drug ID BADD_D01106
Description Not Available
Indications and Usage Not Available
Marketing Status experimental
ATC Code G03DA03
DrugBank ID DB14570
KEGG ID D08052
MeSH ID D000077713
PubChem ID 6238
TTD Drug ID D00AEQ
NDC Product Code 73309-243
UNII 21807M87J2
Synonyms 17 alpha-Hydroxyprogesterone Caproate | 17 alpha Hydroxyprogesterone Caproate | 17-alpha-Hydroxy-Progesterone Caproate | 17 alpha Hydroxy Progesterone Caproate | Caproate, 17-alpha-Hydroxy-Progesterone | Oxyprogesterone Caproate | Hydroxyprogesterone Caproate | Hydroxyprogesterone Hexanoate | 17 alpha-Oxyprogesterone Capronate | 17 alpha Oxyprogesterone Capronate | 17-Hydroxyprogesterone Capronate | 17 Hydroxyprogesterone Capronate | Prolutin Depot | Proluton Depot | Neolutin | Makena | Delalutin
Chemical Information
Molecular Formula C21H30O3
CAS Registry Number 68-96-2
SMILES CC(=O)C1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abortion spontaneous18.01.04.001--Not Available
Asthenia08.01.01.001--Not Available
Body temperature increased13.15.01.001--Not Available
Cervical incompetence21.06.01.008; 18.02.02.009--Not Available
Chest discomfort22.12.02.002; 08.01.08.019; 02.02.02.009--Not Available
Chest pain22.12.02.003; 08.01.08.002; 02.02.02.011--Not Available
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Dizziness24.06.02.007; 17.02.05.003; 02.11.04.006--
Dyspnoea02.11.05.003; 22.02.01.004--
Erythema23.03.06.001--Not Available
Fatigue08.01.01.002--
Feeling hot08.01.09.009--Not Available
Flushing23.06.05.003; 08.01.03.025; 24.03.01.002--
Gestational diabetes18.02.04.001; 14.06.01.008; 05.06.01.008--Not Available
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Infection11.01.08.002--Not Available
Injection site pain12.07.03.011; 08.02.03.010--Not Available
Injection site pruritus23.03.12.007; 12.07.03.014; 08.02.03.013--Not Available
Injection site reaction12.07.03.015; 08.02.03.014--
Menopausal symptoms21.02.02.002--Not Available
Nausea07.01.07.001--
Nervous system disorder17.02.10.001--Not Available
Oligohydramnios18.05.01.001--Not Available
Pre-eclampsia20.01.08.002; 18.02.03.002; 24.08.07.002--Not Available
Pregnancy18.08.02.004--Not Available
Premature baby18.04.02.001--Not Available
Premature delivery18.07.01.006--
Premature labour18.07.01.002--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages